Authors: CHABOT GG ABIGERGES D CATIMEL G CULINE S DEFORNI R EXTRA JM MAHJOUBI H HERAIT P ARMAND JP BUGAT R CLAVEL M MARTY ME

Citation: Gg. Chabot et al., POPULATION PHARMACOKINETICS AND PHARMACODYNAMICS OF IRINOTECAN (CPT-11) AND ACTIVE METABOLITE SN-38 DURING PHASE-I TRIALS, Annals of oncology, 6(2), 1995, pp. 141-151